We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $22.8B
1-Year Est. Return 25.09%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+25.09%
3 Year Est. Return
+81.82%
5 Year Est. Return
+99.92%
10 Year Est. Return
+339.81%
AUM
$18.2B
AUM Growth
-$579M
Cap. Flow
-$1.77B
Cap. Flow %
-9.75%
Top 10 Hldgs %
48.07%
Holding
1,245
New
495
Increased
330
Reduced
167
Closed
55

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$279M
2
PYPL icon
PayPal
PYPL
+$271M
3
MSFT icon
Microsoft
MSFT
+$256M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$118M
5
ORCL icon
Oracle
ORCL
+$104M

Sector Composition

Rank Sector Weight
1 Financials 24.3%
2 Technology 18.32%
3 Communication Services 14.92%
4 Healthcare 13.31%
5 Consumer Staples 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
576
Expeditors International
EXPD
$24B
$31K ﹤0.01%
+475
New +$29.1K
AMKR icon
577
Amkor Technology
AMKR
$13.8B
$30K ﹤0.01%
2,985
BATRK icon
578
Atlanta Braves Holdings Series B
BATRK
$3.4B
$30K ﹤0.01%
1,363
+130
+11% +$3.04K
CI icon
579
Cigna
CI
$73.3B
$30K ﹤0.01%
150
+26
+21% +$5.17K
IPGP icon
580
IPG Photonics
IPGP
$3.71B
$30K ﹤0.01%
139
+50
+56% +$10.6K
VCIT icon
581
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
$30K ﹤0.01%
+340
New +$29.8K
VVV icon
582
Valvoline
VVV
$4.25B
$30K ﹤0.01%
1,193
+27
+2% +$652
GG
583
DELISTED
Goldcorp Inc
GG
$30K ﹤0.01%
2,325
+250
+12% +$3.23K
AUPH icon
584
Aurinia Pharmaceuticals
AUPH
$2.06B
$29K ﹤0.01%
6,500
BIV icon
585
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$29K ﹤0.01%
+345
New +$29.1K
EFX icon
586
Equifax
EFX
$21.2B
$29K ﹤0.01%
247
-1,016
-80% -$114K
KRE icon
587
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$29K ﹤0.01%
+500
New +$28.7K
LLL
588
DELISTED
L3 Technologies, Inc.
LLL
$29K ﹤0.01%
146
HUM icon
589
Humana
HUM
$46.7B
$28K ﹤0.01%
113
-227
-67% -$56.1K
UTHR icon
590
United Therapeutics
UTHR
$21.9B
$28K ﹤0.01%
190
+30
+19% +$3.81K
VMC icon
591
Vulcan Materials
VMC
$36.3B
$28K ﹤0.01%
216
+15
+7% +$1.83K
VRTX icon
592
Vertex Pharmaceuticals
VRTX
$133B
$28K ﹤0.01%
185
+9
+5% +$1.33K
BCS.PRD.CL
593
DELISTED
Barclays Bank Plc
BCS.PRD.CL
$28K ﹤0.01%
+1,050
New +$28K
BURL icon
594
Burlington
BURL
$22.3B
$27K ﹤0.01%
220
+55
+33% +$5.6K
CSL icon
595
Carlisle Companies
CSL
$15.2B
$27K ﹤0.01%
237
+35
+17% +$3.82K
JBGS
596
JBG SMITH
JBGS
$691M
$27K ﹤0.01%
786
-6
-0.8% -$198
LDOS icon
597
Leidos
LDOS
$17.6B
$27K ﹤0.01%
+416
New +$26.1K
NI icon
598
NiSource
NI
$20.1B
$27K ﹤0.01%
+1,059
New +$28.1K
STLD icon
599
Steel Dynamics
STLD
$37.7B
$27K ﹤0.01%
615
+215
+54% +$8.27K
VTWG icon
600
Vanguard Russell 2000 Growth ETF
VTWG
$1.56B
$27K ﹤0.01%
+200
New +$26.5K

Similar funds

Brown Brothers Harriman & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Brown Brothers Harriman & Co held 1,245 positions worth $18.2B, down 3.1% from $18.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Brown Brothers Harriman & Co withdrew a net $1.77B in Q4 2017, closing 55 positions and reducing 167 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $3.14M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Brown Brothers Harriman & Co opened a new position in ATN International worth $27.9M.

  • Brown Brothers Harriman & Co's largest Q4 2017 buy was ATN International: 505,392 shares worth $27.9M.
  • Brown Brothers Harriman & Co added most to Henry Schein in Q4 2017, an estimated $59.8M increase.
  • Brown Brothers Harriman & Co's biggest Q4 2017 reduction was Zoetis, cutting an estimated $279M.
  • Brown Brothers Harriman & Co fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $3.14M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 48% of its $18.2B portfolio in Q4 2017.
  • Brown Brothers Harriman & Co opened 495 new positions and closed 55 in Q4 2017.
  • Brown Brothers Harriman & Co's portfolio value fell 3.1% quarter-over-quarter to $18.2B.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2017, filed 14 Feb 2018.